Cargando…

First Line Systemic Treatment for MALT Lymphoma—Do We Still Need Chemotherapy? Real World Data from the Medical University Vienna

SIMPLE SUMMARY: The Division of Oncology at the Medical University Vienna is a tertiary referral center for extranodal lymphoma of mucosa-associated lymphoid tissue (MALT)-type and currently oversees more than 400 patients with this diagnosis, including a relevant percentage of patients being treate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kiesewetter, Barbara, Simonitsch-Klupp, Ingrid, Mayerhoefer, Marius E., Dolak, Werner, Lukas, Julius, Raderer, Markus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7761357/ https://www.ncbi.nlm.nih.gov/pubmed/33256131 http://dx.doi.org/10.3390/cancers12123533

Ejemplares similares

Depth of Remission Following First-Line Treatment Is an Independent Prognostic Marker for Progression-Free Survival in Gastric Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma
por: Kiesewetter, Barbara, et al.
Publicado: (2020)

Prolonged follow‐up on lenalidomide‐based treatment for mucosa‐associated lymphoid tissue lymphoma (MALT lymphoma)—Real‐world data from the Medical University of Vienna
por: Kiesewetter, Barbara, et al.
Publicado: (2019)

Successful Clarithromycin Monotherapy in a Patient with Primary Follicular Lymphoma of the Duodenum
por: Kiesewetter, Barbara, et al.
Publicado: (2018)

Treatment of mucosa associated lymphoid tissue lymphoma with a long‐term once‐weekly regimen of oral azithromycin: Results from the phase II MALT—A trial
por: Lagler, Heimo, et al.
Publicado: (2018)

Does Delayed-Time-Point Imaging Improve 18F-FDG-PET in Patients With MALT Lymphoma?: Observations in a Series of 13 Patients
por: Mayerhoefer, Marius E., et al.
Publicado: (2016)

18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging
por: Giraudo, Chiara, et al.
Publicado: (2016)

Transformed mucosa‐associated lymphoid tissue lymphomas: A single institution retrospective study including polymerase chain reaction‐based clonality analysis
por: Kiesewetter, Barbara, et al.
Publicado: (2019)

Prevalence of clarithromycin-resistant Helicobacter pylori strains in gastric mucosa-associated lymphoid tissue lymphoma patients
por: Bilgilier, Ceren, et al.
Publicado: (2016)

RECIL Versus Lugano for Treatment Response Assessment in FDG-Avid Non-Hodgkin Lymphomas: A Head-to-Head Comparison in 54 Patients
por: Berzaczy, Dominik, et al.
Publicado: (2019)

Clinical Features, Treatment and Outcome of Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma of the Ocular Adnexa: Single Center Experience of 60 Patients
por: Kiesewetter, Barbara, et al.
Publicado: (2014)

CXCR4 PET/MRI for follow-up of gastric mucosa–associated lymphoid tissue lymphoma after first-line Helicobacter pylori eradication
por: Mayerhoefer, Marius E., et al.
Publicado: (2022)

How I treat MALT lymphoma: ‘a subjective interpretation of the gospel according to Isaacson….’
por: Raderer, Markus, et al.
Publicado: (2020)

CXCR4 PET imaging of mantle cell lymphoma using [(68)Ga]Pentixafor: comparison with [(18)F]FDG-PET
por: Mayerhoefer, Marius E., et al.
Publicado: (2021)

What you always wanted to know about gastric MALT-lymphoma: a focus on recent developments
por: Raderer, Markus, et al.
Publicado: (2021)

Evaluation of [18F]-FDG-Based Hybrid Imaging Combinations for Assessment of Bone Marrow Involvement in Lymphoma at Initial Staging
por: Asenbaum, Ulrika, et al.
Publicado: (2016)

Prospective non-invasive evaluation of CXCR4 expression for the diagnosis of MALT lymphoma using [(68)Ga]Ga-Pentixafor-PET/MRI
por: Haug, Alexander R., et al.
Publicado: (2019)

Ultra-early response assessment in lymphoma treatment: [(18)F]FDG PET/MR captures changes in glucose metabolism and cell density within the first 72 hours of treatment
por: Mayerhoefer, Marius E., et al.
Publicado: (2018)

Is there a reliable size cut-off for splenic involvement in lymphoma? A [18F]FDG-PET controlled study
por: Berzaczy, Dominik, et al.
Publicado: (2019)

Long-term Therapeutic Success of Intravenous Rituximab in 26 Patients with Indolent Primary Cutaneous B-cell Lymphoma
por: PORKERT, Stefanie, et al.
Publicado: (2021)

Treatment patterns and oncological outcome of patients with advanced small intestinal neuroendocrine tumors: real-world data from the Medical University of Vienna
por: Melhorn, Philipp, et al.
Publicado: (2022)

Pulmonary neuroendocrine tumours and somatostatin receptor status: an assessment of unlicensed use of somatostatin analogues in the clinical practice
por: Kiesewetter, B., et al.
Publicado: (2022)

Azithromycin concentrations during long-term regimen, a pilot study in patients with MALT lymphoma
por: Scheibenpflug, Raphael, et al.
Publicado: (2021)

Importance of extensive staging in patients with mucosa-associated lymphoid tissue (MALT)-type lymphoma
por: Raderer, M, et al.
Publicado: (2000)

Tailoring treatment for MALT lymphoma patients: where do we stand now?
por: Johnson, Peter W., et al.
Publicado: (2017)

Molecular Pathogenesis of MALT Lymphoma
por: Troppan, Katharina, et al.
Publicado: (2015)

Clinical relevance of molecular aspects in extranodal marginal zone lymphoma: a critical appraisal
por: Raderer, Markus, et al.
Publicado: (2023)

We still need to operate at night!
por: Faiz, Omar, et al.
Publicado: (2007)

Do we still need supertrees?
por: Haeseler, Arndt von
Publicado: (2012)

Genetic Characterization and Clinical Features of Helicobacter pylori Negative Gastric Mucosa-Associated Lymphoid Tissue Lymphoma
por: Kiesewetter, Barbara, et al.
Publicado: (2021)

Thyroid MALT lymphoma: self-harm to gain potential T-cell help
por: Wu, Fangtian, et al.
Publicado: (2021)

Can we still stop the migration of physicians from Austria?: An evaluation of clinical internships by students of the Medical University of Vienna
por: Seitz, Tamara, et al.
Publicado: (2016)

Gastric MALT lymphoma and Helicobacter pylori.
por: Wotherspoon, A. C.
Publicado: (1996)

Dural MALT lymphoma with disseminated disease
por: Matmati, Kelly, et al.
Publicado: (2010)

MALT lymphoma meets stem cells
por: Vicente-Dueñas, Carolina, et al.
Publicado: (2012)

Recent Advances in the Genetic of MALT Lymphomas
por: Rodríguez-Sevilla, Juan José, et al.
Publicado: (2021)

Protocol for generating a mouse model of gastric MALT lymphoma and the identification of MALT lymphoma cell populations by immunostaining
por: Yamamoto, Koji, et al.
Publicado: (2022)

The European Society for Medical Oncology 'Magnitude of Clinical Benefit Scale' field-tested in infrequent tumour entities: an extended analysis of its feasibility at the Medical University of Vienna
por: Kiesewetter, Barbara, et al.
Publicado: (2017)

Novel GPR34 and CCR6 mutation and distinct genetic profiles in MALT lymphomas of different sites
por: Moody, Sarah, et al.
Publicado: (2018)

The European Society for Medical Oncology Magnitude of Clinical Benefit Scale in daily practice: a single institution, real-life experience at the Medical University of Vienna
por: Kiesewetter, Barbara, et al.
Publicado: (2016)

A Case of a Laryngeal MALT Lymphoma in a Patient with a History of Gastric MALT
por: Ashamalla, Mark, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_e8qgqd5ihnk5ofpp9bl6s2vqm6